NGL Fine-Chem Limited (NGLFINE.BO)

INR 1060.0

(0.15%)

Net Debt Summary of NGL Fine-Chem Limited

NGL Fine-Chem Limited's latest annual net debt in 2023 was 307.22 Million INR , up 35.64% from previous year.
NGL Fine-Chem Limited's latest quarterly net debt in 2023 FY was 307.22 Million INR , up 35.64% from previous quarter.
NGL Fine-Chem Limited reported annual net debt of 226.5 Million INR in 2022, down -22.85% from previous year.
NGL Fine-Chem Limited reported annual net debt of 293.57 Million INR in 2021, up 104.65% from previous year.
NGL Fine-Chem Limited reported quarterly net debt of 307.22 Million INR for 2023 FY, up 35.64% from previous quarter.
NGL Fine-Chem Limited reported quarterly net debt of 264.61 Million INR for 2023 Q2, down 0.0% from previous quarter.

Annual Net Debt Chart of NGL Fine-Chem Limited (2023 - 2008)

Historical Annual Net Debt of NGL Fine-Chem Limited (2023 - 2008)

Year	Net Debt	Net Debt Growth
2023	307.22 Million INR	35.64%
2022	226.5 Million INR	-22.85%
2021	293.57 Million INR	104.65%
2020	143.45 Million INR	-48.46%
2019	278.32 Million INR	5.53%
2018	263.73 Million INR	4.73%
2017	251.8 Million INR	11.14%
2016	226.57 Million INR	61.64%
2015	140.17 Million INR	50.75%
2014	92.98 Million INR	-41.73%
2013	159.58 Million INR	53.87%
2012	103.71 Million INR	29.68%
2011	79.97 Million INR	61.91%
2010	49.39 Million INR	23.24%
2009	40.07 Million INR	31.36%
2008	30.51 Million INR	0.0%

Year	Net Debt	Net Debt Growth
2023 Q3	- INR	-100.0%
2023 FY	307.22 Million INR	35.64%
2023 Q2	264.61 Million INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q4	307.22 Million INR	0.0%
2022 FY	226.5 Million INR	-22.85%
2022 Q2	174.48 Million INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q4	226.5 Million INR	0.0%
2021 Q2	185.87 Million INR	0.0%
2021 Q3	- INR	-100.0%
2021 Q4	293.57 Million INR	0.0%
2021 FY	293.57 Million INR	104.65%
2021 Q1	- INR	-100.0%
2020 Q2	173.11 Million INR	0.0%
2020 Q4	143.45 Million INR	0.0%
2020 FY	143.45 Million INR	-48.46%
2019 Q4	278.32 Million INR	0.0%
2019 FY	278.32 Million INR	5.53%
2019 Q2	202.75 Million INR	0.0%
2018 FY	263.73 Million INR	4.73%
2018 Q4	263.73 Million INR	0.0%
2018 Q2	252.43 Million INR	0.0%
2017 Q2	205.62 Million INR	0.0%
2017 Q4	251.8 Million INR	0.0%
2017 FY	251.8 Million INR	11.14%
2016 Q2	96.45 Million INR	0.0%
2016 FY	226.57 Million INR	61.64%
2016 Q4	226.4 Million INR	0.0%
2015 Q2	107.31 Million INR	0.0%
2015 Q4	106.37 Million INR	0.0%
2015 FY	140.17 Million INR	50.75%
2014 FY	92.98 Million INR	-41.73%
2014 Q4	92.98 Million INR	0.0%
2014 Q2	95.08 Million INR	0.0%
2013 Q4	159.58 Million INR	0.0%
2013 FY	159.58 Million INR	53.87%
2013 Q2	111.15 Million INR	0.0%
2012 Q4	103.71 Million INR	0.0%
2012 FY	103.71 Million INR	29.68%
2011 Q4	79.97 Million INR	0.0%
2011 FY	79.97 Million INR	61.91%
2010 FY	49.39 Million INR	23.24%
2009 FY	40.07 Million INR	31.36%
2008 FY	30.51 Million INR	0.0%
2008 Q4	30.51 Million INR	0.0%

Peer Net Debt Comparison of NGL Fine-Chem Limited

Name	Net Debt	Net Debt Difference
Abbott India Limited	-20.51 Billion INR	101.498%
Cipla Limited	-3.15 Billion INR	109.736%
Gland Pharma Limited	-14.67 Billion INR	102.094%
GlaxoSmithKline Pharmaceuticals Limited	-674.11 Million INR	145.575%
Kopran Limited	850.3 Million INR	63.869%
Marksans Pharma Limited	-4.29 Billion INR	107.153%
Pfizer Limited	-19.52 Billion INR	101.574%
Sanofi India Limited	-3.87 Billion INR	107.928%
SMS Pharmaceuticals Limited	2.44 Billion INR	87.438%